In neonates with patent ductus arteriosus (PDA), two CYP2C9 polymorphisms (rs2153628 and rs1799853) were identified to be associated with Indomethacin response and treatment of PDA [76]. Here, CYP2C9 is linked to Patent ductus arteriosus.